P1.06-046 Can We Better Manage Advanced NSCLC in the Elderly With the New Therapeutic Agents? Preliminary Analysis of a Real-Life Multicenter Study

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2016.11.910
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Can We Manage B3 Lesions Better?

Breast Cancer Research
Cancer ResearchOncology
2008English

How Can We Manage Intimate Partner Violence Better?

South African Medical Journal
Medicine
2016English

Fall Risk Assessment Tools for Elderly Living in the Community: Can We Do Better?

PLoS ONE
Multidisciplinary
2015English

Can We Do Better? Economic Analysis of Human Resource Investment to Improve Home Care Service for the Elderly in Serbia

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2016English

Can We Build a Better Allograft?

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

How Can We Help Family Carers Manage Pain Medicines for Patients With Advanced Cancer? A Systematic Review of Intervention Studies

BMJ Supportive and Palliative Care
Surgical NursingMedicineMedicalOncology
2016English

Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: A Retrospective Multicenter Cohort Study

Scientific Reports
Multidisciplinary
2016English

P1.01-14 Immunotherapy (I) for Advanced, Pre-Treated, Non-Squamous NSCLC (APNS-NSCLC). Preliminary Data of a Pooled Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy